Aminotransferases (ATs) are important biocatalysts for the synthesis of chiral amines because of their capability of introducing amino group into ketones or keto acids as well as their high enantioselectivity, high regioselectivity. Among all ATs, branchedchain amino acid aminotransferase (BCAT) can use branched-chain amino acids (BCAAs) as substrate, including L -valine, Lleucine, and L -isoleucine, with α-ketoglutarate to form the corresponding α-keto acids and L -glutamate. Alternatively, BCATs have been used for the biosynthesis of unnatural amino acids, such as L -tert-leucine and L -norvaline. In the present study, the BCAT from Pseudomonas sp. (PsBCAT) was cloned and expressed in Escherichia coli for biochemical and structural analyses. The optimal reaction temperature and pH of PsBCAT were 40°C and 8.5, respectively. PsBCAT exhibited a comparatively broader substrate spectrum and showed remarkably high activity with bulked aliphatic L -amino acids (k cat up to 220 s
Introduction
Enantiopure chiral amines are important building blocks in the synthesis of optically active pharmaceuticals, fine chemicals, agrochemicals, and bioactive natural products due to their structural diversity and functional versatility (Ghislieri and Turner 2014; Patel 2013; Simon et al. 2013) . The impressive number of applications of chiral amines has stimulated a great deal of innovation in synthetic methodologies for their preparation (Xue et al. 2018) . Within the expanding biocatalytic toolbox for amine synthesis, ATs represent an attractive alternative with excellent optical purity, quantitative yields, and high enantioselectivity (Liu et al. 2019; P Taylor et al. 1998; Paul et al. 2014) . A number of excellent reviews have been published describing the common features of aminotransferases (Hwang et al. 2005; Taylor et al. 1998; Xue et al. 2018) . In general, ATs catalyze the amino group transfer from an Xinxin Zheng and Yinglu Cui contributed equally to this work.
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The online version of this article (https://doi.org/10.1007/s00253-019-10105-9) contains supplementary material, which is available to authorized users. amino donor to a ketone or aldehyde with pyridoxal 5′-phosphate (PLP) as cofactor. The first step of the reaction is the transfer of the amino group to the cofactor covalently bound to an active site lysine via a Schiff base, resulting in the formation of pyridoxamine-5′-phosphate (PMP) and release of the amino donor as a ketone or aldehyde. The second step is the regeneration of PLP with the transfer of the amino group to the amino acceptor, which is released as a chiral amino acid if the acceptor is a ketone or a primary amine if the acceptor is an aldehyde (Toney 2014) .
PLP-dependent enzymes can be grouped into four subgroups: α family, β family, D -alanine aminotransferases family, and alanine racemase family (Jansonius 1998) . Among the four subgroups, all ATs belong to α family except for ВСАТs and D -amino acid aminotransferases (DATs), which belong to the D -alanine aminotransferase family Hwang et al. 2005) . Structural similarity and sequence alignment analysis conducted by the Protein Family Database (Pfam) suggest that ATs are divided into six subgroups or classes, with classes I and II including L -aspartate aminotransferases (AspATs) and L -aromatic amino acid aminotransferases (AroATs), class III ω-transaminases (ω-ATs), class IV BCATs and DATs, class V L -serine aminotransferases, and class VI sugar aminotransferases (Finn et al. 2014) .
Among all ATs, ВСАТs are specific for catalyzing transamination of proteinogenic BCAAs, such as L -leucine, L -isoleucine and L -valine, with α-ketoglutarate to form the respective branched-chain α-keto acids and L -glutamate. Alternatively, BCATs have been used for the biosynthesis of unnatural chiral amino acids, including L -tert-leucine, Lnorvaline, L -norleucine, and L -phenylglycine (Xue et al. 2018) . Incorporation of unnatural chiral amino acids into peptide drug serves an important strategy in the synthesis of biologically active compounds with better bioavailability and enhanced potency of the modified target molecules (Gentilucci et al. 2010; Rudat et al. 2012) .
Because the reaction equilibrium for α-ATs typically lies close to unity, the reversibility of the α-AT-catalyzed reactions generally leads to a low conversion. The presence of α-keto acids and amino acids in the reaction prevents efficient product recovery. In addition, inhibition of the by-product ketone also prevents efficient conversion. Shifting the equilibrium toward the product direction is required in the synthesis (Xue et al. 2018) . Therefore, the biosynthesis of unnatural chiral amino acids has been achieved by coupling BCATs with several enzymes, including ornithine-δ-aminotransferase (OAT) (Li et al. 2002) , AspAT/pyruvate decarboxylase (PDC) (Seo and Yun 2011) , ω-AT (Park and Shin 2015) , and GluDH/FDH (Hong et al. 2010) . However, the quality of the coupling systems largely depends on the properties of the target production. The crucial setbacks in the scale-up of the most BCTA coupling reactions include low catalytic efficiency, cumbersome steps, and high cost. It is apparent that the pool of enzymes effectively suitable for these biotransformations is limited, new sources and novel enzymes are currently being investigated.
Here, we successfully expressed and purified BCAT from Pseudomonas sp. (PsBCAT) and described enzymatic properties, including optimal reaction pH and optimal reaction temperature. The substrate specificity and kinetic parameters of several typical specific substrates were also determined. To further study its structure-function feature, the threedimensional crystal structure combined with PLP was determined. In addition, compared with BsBCAT, CgBCAT, and EcBCAT, PsBCAT exhibited the highest activities in most aliphatic amino acids, and the feasibility of L -tert-leucine and L -norvaline synthesis was also verified.
Materials and methods

Sequence similarity networks (SSN) analysis
A sequence similarity network of the BCAT family proteins (57,443 sequences, PFam01063 from Pfam release 31.0) was created using EFI-EST web tools (Finn et al. 2014; Gerlt et al. 2015) . In the first round, 57,443 sequences from Pf01063 were clustered by 90% identity to 30,927 sequences for alignment, and a network with an E-value cut-off 10 −190 was created and visualized using the default layout in Cytoscape 3.7.1 (Shannon et al. 2003) . To filter out highly conservative sequences and mine sequences with different kinship, nodes with multiple InterPro annotations containing more than 40 sequences from at least 2 prokaryotic genera and not grouped in networks were chosen as input sequences for the next round of analysis (Mitchell et al. 2019 ). The second network was built with an E value cut-off 10 −75 to exclude ungrouped nodes. The results were displayed in Cytoscape using 50% identity RepNodes to obtain higher resolution. The second network grouped the RepNodes into 3 clusters. Sequences in 3 groups were retrieved for the third analysis. The third network had an E value cut-off 10 −3 and was colored by family.
Families with less than 3 nodes were deleted.
Cloning, expression, and purification of BCATs and BsOrnAT
The ilvE gene of PsBCAT was codon-optimized and synthes i z e d b y G e n e r a l B i o s y s t e m s ( A c c e s s i o n N O . NMDCAA000001, available: http://gcm.wdcm.org/typestrain/ nucleotide/NMDCAA000001). The synthetic PsBCAT gene was inserted into NdeI and XhoI sites of the pET-28a expression vector. The ilvE gene encoding Bacillus subtilis (strain 168) BCAT (BsBCAT, Genebank Accession NO. AQR80175), Corynebacterium glutamicum ATCC13032 BCAT (CgBCAT, Genebank Accession NO. AUI01653) (Marienhagen et al. 2005) , Escherichia coli BL21(DE3) (Invitrogen, Beijing, China) BCAT (EcBCAT, Genebank Accession NO. CAQ34114) (Kagamiyama and Hayashi 2000) , and the rocD gene encoding Bacillus subtilis (strain 168) OAT (BsOrnAT, Genebank Accession NO. AQR84080) were amplified using corresponding primers from the genomes. The strains of Bacillus subtilis (strain 168) and Corynebacterium glutamicum ATCC13032 were purchased from China General Microbiological Culture Collection Center (Beijing, China). The amplified products were assembled into the corresponding position of pET-28a using the Gibson assembly method and then transformed into E. coli Top10 for screening (Gibson et al. 2009 ). All primers used above were presented in Table S1 . Finally, the target plasmids were verified by sequencing (Tsingke, Beijing, China). E. coli BL21(DE3) carrying the recombinant plasmid was cultivated at 30°C in 1 L auto-induction cultures (10 g/L tryptone, 5 g/L yeast extract, 3.3 g/L ammonium sulfate, 6.8 g/L monopotassium phosphate, 17.9 g/L disodium hydrogen phosphate, 0.55 g/L glucose, 2.1 g/L lactose, 0.49 g/L magnesium sulfate, 2.0 mL/L glycerol) containing 50 μg/mL kanamycin for the expression of recombinant proteins. After 20 h of induction, the cells were harvested, resuspended in 20 mM phosphate buffer (pH = 7.5) containing 0.5 M sodium chloride and 20 mM imidazole, and disrupted by sonication. The crude cell extract was centrifuged for 60 min at 18,000 g, and supernatants were prepared for further purification. Crude enzyme solution was loaded into Ni-NTA obtained from GE and washed with 50 mL solution buffer (pH = 7.5) containing 20 mM imidazole, 20 mM phosphate, and 0.5 M sodium chloride. Then, the proteins were eluted with elution buffer (pH = 7.5) containing 0.5 M imidazole, 20 mM phosphate, and 0.5 M sodium chloride and desalted with a phosphate buffer (pH = 7.5) containing 20 mM phosphate. Finally, the molecular weight of PsBCAT was analyzed by 12% SDS-PAGE. Purified enzymes were stored in a − 20°C refrigerator for further research. The protein concentration was quantified by measuring A 280 nm (1 Abs = 1 mg/mL). All chemicals, including antibiotics, medium material, and imidazole, were obtained from Sigma-Aldrich.
Enzyme activity assay
The activity of recombinant PsBCAT was determined using L -valine as an amino donor and α-ketoglutarate as the amino receptor. The reaction was performed at 37°C and pH 8.5 (50 mM Tris-HCl buffer) with 10 mM L -valine, 4 mM α-ketoglutarate, 10 μM PLP, and 10 μg purified enzyme in a total volume of 1 mL. The initial rate was determined within 30 min. Reactions were terminated by 1 M HCl, and the concentration of α-ketoisovalerate was analyzed using a C 18 column (250 × 4.6 mm, particle size 5 μM) with a Shimadzu HPLC system at 210 nm. Separation of the target component was achieved through an isocratic elution with a mixture of 5% acetonitrile and 95% water (0.1% formic acid) at a flow rate of 1.0 mL/min. One unit of enzyme activity was defined as the amount of enzyme that can produce 1 μmol of α-ketoisovalerate per min. All experiments were performed in triplicate.
Effect of pH, temperature, and PLP on PsBCAT activity
The optimum pH for the reaction with 10 mM L -valine, 4 mM α-ketoglutarate, and 10 μM PLP was determined at 37°C as described above using the following buffers: 50 mM Na 2 HPO 4 -citric acid buffer (pH 5.0-7.0), 50 mM Tris-HCl buffer (pH 7.0-9.0), and 50 mM Gly-NaOH buffer (pH 9.0-10.5). The optimal temperature was estimated in 50 mM Tris-HCl buffer (pH 8.5) with 10 mM L -valine, 4 mM α-ketoglutarate, and 10 μM PLP under different temperature (25~55°C). The effect of PLP concentration on activity was tested at 37°C by performing 10 mM L -valine and 4 mM α-ketoglutarate reactions in 50 mM Tris-HCl buffer (pH 8.5) (22).
Substrate specificity
The substrate specificity of the PsBCAT for amino acids as amino donors was investigated using α-ketoglutarate as the amino acceptor (for glutamate; α-ketoisovalerate was chosen as amino acceptor). The reaction mixture consists of 10 mM amino donors, 4 mM α-ketoglutarate, and 10 μM PLP in 50 mM Tris-HCl (pH 8.5) at 37°C. Reactions were terminated by 1 M HCl, and the reduction of α-ketoglutarate was analyzed by HPLC. The specificity for amino acceptors was conducted at the same condition with glutamate as amino donors (for α-ketoglutarate, valine as amino donor). Reactions were terminated by 1 M HCl, and the increase of α-ketoglutarate was analyzed by HPLC.
Kinetic analysis
For steady-state kinetic analysis, apparent kinetic constants of PsBCAT for L -valine, L -leucine, L -isoleucine, and L -tert-leucine ranging from 0 to 50 mM were determined at a fixed concentration of α-ketoglutarate in 1 mL reaction mixtures containing 50 mM Tris-HCl (pH 8.5) and 10 μM PLP at room temperature. For L -glutamate, kinetic constants were measured simultaneously but with a fixed concentration of α-ketoisovalerate as amino acceptor. In the reverse direction, apparent kinetic constants of α-keto acids were measured as well. Apparent K m and V max values were calculated by fitting the Michaelis-Menten equation to the experimental data using the non-linear least-squares fit mode of Origin 9.0.
Crystallization, data collection, and structure determination Crystals of PsBCAT were obtained using the hangingdrop vapor-diffusion method at 16°C by mixing equal volumes of protein (12 mg/mL) and reservoir solution that contained 0.25 M ammonium citrate dibasic and 20% (w/v) PEG 3350. The crystals were soaked in reservoir solution supplied with an additional 20% (v/v) glycerol and then flash-frozen in liquid nitrogen. The diffraction datasets were collected at the Shanghai Synchrotron Radiation Facility (SSRF, China) on a beamline BL19U1 with a wavelength of 0.9789 Å at 100 K. The data were processed with XDS and CCP4 (Kabsch 2010; Winn et al. 2011) . Initial phases were obtained by molecular replacement with PHASER using the structure of branched-chain aminotransferase from Deinococcus radiodurans (PDB entry 3UYY) as a search model (Chen et al. 2012; McCoy et al. 2007) . The model of PsBCAT was automatically and manually built by PHENIX.AUTOBUILD (Adams et al. 2010 ) and COOT (Emsley and Cowtan 2004) , respectively, and refined with PHENIX. The data collection and refinement statistics were summarized in Table 1 . The coordinates and structure factors for PsBCAT have been deposited in the Protein Data Bank under accession 6JIF.
Molecular docking
L -glutamate and L -tert-leucine were docked into the active site of PsBCAT using Autodock 4.2 (Morris et al. 2009 ). The simulation box was fixed around PLP, with box size 60 Å in all three dimensions, and with all other settings set to default values. Collected conformations were then clustered based on the root-mean-square deviations (RMSD) against the conformation with the lowest binding energy (Shao et al. 2007 ). The maximum number of Lamarckian genetic algorithm runs was set to 100. Finally, the complex with the lowest docking energy among the 100 obtained conformations was selected as the model for subsequent analysis.
Biosynthesis of chiral amino acids
To shift the unfavorable equilibrium, PsBCAT coupling with BsOrnAT was applied to synthesize L -tert-leucine and L -norvaline. The reaction mixture contained 0.5 M Tris-HCl buffer (pH 8.5), 0.1 M trimethylpyruvate or α-ketovalerate, 20 mM sodium glutamate, 80 mM L -ornithine monohydrochloride, 20 μM PLP and 0.2 mg PsBCAT, and 0.05 mg BsOrnAT enzyme in a total volume of 5 mL at 30°C. The concentration of L -tert-leucine and L -norvaline was analyzed by HPLC after derivatized using dinitrofluorobenzene (DNFB) with a C 18 column (250 × 4.6 mm, particle size 5 μM) and Shimadzu HPLC system at 360 nm (Li et al. 2018) . The enantiomeric purities of Lnorvaline and L -tert-leucine were analyzed using S h i m a d z u H P L C s y s t e m w i t h a c h i r a l c o l u m n (CHIRALPAK® IG, 250 × 4.6 mm, particle size 5 μM). In order to analyze chiral compounds, the samples were derivatized with DNFB as the same. 
Cloning, expression, and purification of BCATs
To discover novel BCATs, BCAT sequences with large sequence diversity were analyzed. Three iterative analyses were performed to remove highly conserved BCAT sequences and filter out sequences with low occurrence. After the third round of analysis, a 788 node network was obtained (Fig. 1) . The representative sequences of the most concentrated clusters (the BCATs from Escherichia. coli, Bacillus subtilis, and Pseudomonas sp.) were chosen for further analysis. In addition, the well-studied BCAT from Corynebacterium glutamicum was also selected (Marienhagen et al. 2005) . A homology search was conducted based on BCAT from E. coli using the blast program against the GenBank database. The BCAT sequences from Bacillus subtilis, Corynebacterium glutamicum, and Pseudomonas sp. exhibit 25%, 13%, and 30% similarities with that of E. coli, respectively. The BCAT proteins were produced primarily as soluble proteins. The expression of PsBCAT was better than other BCATs with 110 mg purified enzyme per liter cultivation (OD 600 nm range of 4-5), BsBCAT (90 mg/L), EcBCAT (54 mg/L) followed, and CgBCAT (28 mg/L) was the least. The purified BCATs of BsBCAT, CgBCAT, EcBCAT, and PsBCAT were electrophoretically homogenous as shown on SDS-PAGE with apparent molecular weights of approximately 40.3 kDa, 41.8 kDa, 35.5 kDa, and 37.3 kDa (Fig. S1 ), respectively. Molecular weights of PsBCAT and EcBCAT are similar with the PsBCAT homologous BCATs, such as DrBCAT (Chen et al. 2012) , SmIlvE (Ruan et al. 2012) and MtIlvE (Tremblay and Blanchard 2009) at 38~39 kDa, but higher than that from Methanococcus aeolicus with molecular masses of 31.8 kDa for each monomer of the hexamers (Xing and Whitman 1992) . The molecular weight of BsBCAT is similar with that of mammalian BCATs, which are commonly found as dimers with molecular masses of 41.3 and 43 kDa for the hBCATm and hBCATc monomers, respectively (Goto et al. 2005; Yennawar et al. 2001) . Among the four BCATs, PsBCAT exhibited the highest activity towards L -tertleucine with 7.0 ± 0.7 U/mg at 37°C and pH 8.5. The activities of BsBCAT, CgBCAT, and EcBCAT were 1.1 ± 0.1 U/mg, 2.0 ± 0.3 U/mg, and 3.6 ± 0.3 U/mg, respectively. Therefore, PsBCAT was chosen for further analysis.
Effect of pH and temperature on PsBCAT activity
The effect of pH on PsBCAT activity was examined over pH values ranging from 5.0 to 10.5 at 37°C (Fig. 2a) . The highest activity of PsBCAT for L -valine was observed at pH 8.5 in 50 mM Tris-HCl buffer, while it decreased significantly with pH values less than 7.5 or greater than 10.0 with only approximately 10% activity or even less. The results were consistent with that of most BCATs, including the thermal BCATs from Vulcanisaeta moutnovskia and Thermoproteus uzoniensis (Bezsudnova et al. 2016; Stekhanova et al. 2017) , the optimum pH of which was observed at pH 8.5.
In terms of temperature, PsBCAT has an optimal temperature typical of most of thermophilic BCATs at 40°C. As shown in Fig. 2b , the PsBCAT activity decreased very quickly to approximately 30% at 50°C, and the apparent melting temperature was 40°C determined by the method of fluorescence-based thermal stability assay (Bu et al. 2018) , indicating that it was denatured at high temperatures.
Investigation of PLP requirement of PsBCAT
The purified PsBCAT showed low activity when assayed in the absence of PLP but was significantly activated in the presence of PLP (Fig. 2c) . The effect of PLP concentration on PsBCAT activity was investigated using L -valine as the substrate, and the Michaelis constant was 3.4 μM. The maximum activity of PsBCAT was observed when the PLP concentration reached 20 μM, and no significant activity increase was noted at higher PLP concentrations. Fig. 1 Representation of the BCATs as a sequence similarity network. In this network, nodes represent individual sequences, and edges represent the alignment score from pairwise alignments. Longer edges represent lower scores. Selected sequences from each cluster are displayed in yellow with a black border.
Substrate specificity and kinetic analysis of PsBCAT
To evaluate the substrate specificity of PsBCAT, we determined its activities toward 25 amino acids and 10 α-keto acids. Among the 35 substrates estimated, PsBCAT was able to catalyze transamination of 19 amino acids, and all α-keto acids were capable of serving as amino acceptors. The specific activity of PsBCAT towards individual substrate was shown in Fig. 3 . With α-ketoglutarate as amino acceptor, PsBCAT exhibited maximum activity toward L -allo-isoleucine followed by L -phenylglycine, L -leucine, L -norvaline, L -valine, and Lisoleucine. Despite the considerably lower activity, PsBCAT also showed activities toward L -phenylalanine, L -alanine, and L -tert-leucine, but it was inert to L -tryptophan, L -tyrosine, Lthreonine, L -histidine, and L -lysine. This substrate screening assay determined that PsBCAT has a broader substrate specificity and prefers to catalyze the transamination of bulked aliphatic amino acids. Moreover, PsBCAT exhibited no activity for amines in propylamine, aniline, and phenylethylamine (data not shown), which indicates the carboxyl group is essential for binding in the active site.
Kinetic analysis of PsBCAT resulted in the determination of the initial velocities at different substrate concentrations. The kinetic parameters of L -leucine, L -isoleucine, L -valine, Lglutamic acid, and L -tert-leucine were determined for these reactions in two-side directions ( Table 2 ). The effects of the concentration of amino donors on the initial rate followed a typical Michaelis-Menten equation. The k cat /K m value of Lleucine was much greater than any others, suggesting that the active site of PsBCAT has evolved to catalyze the transamination reaction for L -leucine most effectively. For L -tertleucine transamination, the K m value (11.5 mM) was approximately fivefold higher than that for L -leucine, and the k cat /K m value was much lower (0.9 s −1 mM
−1
). Since previous reports have shown that the enzyme activities of aminotransferases were affected by the product or substrate concentrations, product or substrate inhibitions extensively exist among BCATs . Kinetics experiments demonstrated that substrate inhibition by L -leucine, L -isoleucine, L -valine, Lglutamic acid, and L -tert-leucine was not observed up to 50 mM. On the contrary, the α-keto acids exhibit significant inhibition of PsBCAT. For example, the reaction rate increased as the concentration of α-ketoglutarate increased up to 5 mM. However, when α-ketoglutarate exceeded 5 mM, the reaction rate was decreased. The reaction rate with 10 mM was 55.4% of that with 5 mM α-ketoglutarate. The α-keto acids inhibition by α-ketoisovalerate was almost the same. The reaction rate with 25 mM was 66.7% of that with 15 mM α-ketoisovaleric acid. As a result, the apparent kinetic parameters of amino acceptors were not obtained.
The overall structure of PsBCAT
To analyze the catalytic mechanism of PsBCAT with a broad substrate spectrum, the crystal structure of PsBCAT was determined at a resolution of 1.9 Å (Fig. 4a) . Structural alignments of PsBCAT with type IV class of PLP dependent enzymes, such as DrBCAT (BCAT from Deinococcus Fig. 2 Effects of pH, temperature, and PLP on the activities of the PsBCAT. a The optimal reaction pH of PsBCAT was 8.5. b The optimal reaction temperature of PsBCAT was 40°C. c The PLP concentration was 20 μM at the peak of enzyme activity. Values shown are means of triplicate determinations ± standard error (SE).
radiodurans, PDB entry 3UYY), SmIlvE (BCAT from Streptococcus mutans, PDB entry 4DQN), and MtIlvE (BCAT from Mycobacterium tuberculosis, PDB entry 3HT5) for all Cα atoms are 0.46 Å, 0.50 Å, and 0.93 Å, respectively, which indicated that PsBCAT shared typical folds of the type IV class of PLP-dependent enzymes.
The asymmetric unit contains one PsBCAT homodimer (Fig. 4a) . Each PsBCAT subunit is built up by two separate domains (Fig. 4b) . The first 7 amino acids at the N-terminal region were disordered and invisible in the density map. The small domain (Asn8 to Pro154 and Ile337 to Val340) displays a Rossmann fold and consists of seven β-strands (β1-β7) and three α-helices (α1-α3). Seven β-strands of this domain run in an up-and-down fashion to form a core antiparallel β-sheet with α1-α3 helices on both sides. The large domain (His166 to Pro312) of PsBCAT consists of nine β-sheets (β8-β16), which are surrounded by three α-helices (α4-α6). These two domains are linked by α7 helix (residues 313-336) and an interdomain loop (Val155 to Pro165). The interdomain helix is expected to provide a rigid framework for stabilization of the two interacting domains, whereas the interdomain loop is proposed to provide flexibility near the active-site entrance 
L -valine 9.2 ± 1.4 220.1 ± 12.0 24.4 ± 2.6 L -leucine 2.3 ± 0.4 165.1 ± 10.4 74.1 ± 9.2 L -isoleucine 2.9 ± 0.8 175.6 ± 24.0 63.9 ± 10.8 L -tert-leucine 11.5 ± 2.9 9.7 ± 0.3 0.9 ± 0.2 L -glutamate 18.7 ± 0.6 105.3 ± 10.0 5.6 ± 0.4 and allow both substrate and product access into and out of the substrate-binding pocket. The active site of PsBCAT The highly conserved residues confer crucial interactions with PLP in the binding pocket of PsBCAT, including Arg83, Lys185, Tyr190, Glu221, Ile248, Thr249, and Thr286 (Fig.  4c) , whereas the corresponding residues are Arg101, Lys204, Tyr209, Glu240, Ile271, Thr272, and Thr314 in MtIlvE; Arg100, Lys202, Tyr207, Glu238, Ile266, Thr237, and Thr304 in DrBCAT; and Arg81, Lys184, Tyr189, Glu220, Val247, Thr248, and Thr285 in SmIlvE. In addition, this positively charged active site pocket is surrounded by residues Phe59, Glu60, Gly61, Tyr126, Arg128, Arg175, Ser224, Ala225, Asn226, Leu245, Gly247, and Gly285.
After docking the ligands into PsBCAT, the enzyme-ligand complexes reveal several essential residues for the ligand binding, and some of these residues are conserved in all BCAT enzymes from various species. In the PsBCAT-L -glutamate complex, Arg128 and Tyr54 confer hydrogen bonds with the γ-carboxylate oxygen atom of L -glutamate, whereas Tyr126 and the backbone H atom of Ala287 make hydrogen bonds with the α-carboxylate oxygen atoms. Ser224 and Tyr190 accept hydrogen bonds from the amide hydrogens of L -glutamate. The binding mode of L -glutamate is similar to that in EcBCAT crystal structure (Goto et al. 2003) . In the PsBCAT-L -tert-leucine complex, Tyr126 and Ala287 also form hydrogen bonds with the α-carboxylate oxygen atom of L -tert-leucine, and the side chain OG atom of Tyr190 and the backbone O atom of Ser224 confer hydrogen-bonding with the amide hydrogens of L -glutamate. Remarkably, in both PsBCAT-amino acid complexes, Tyr54, Tyr126, and Lys128 make a hydrogen-bonding network to stabilize the carboxylate oxygen atom of the amino acids. The detailed interactions among residues, PLP, and the L -glutamate/ L -tert-leucine molecules are shown in Fig. 4d and e.
Application of PsBCAT for chiral amino acids biosynthesis
Enantiopure aliphatic amino acids, including L -tert-leucine and L -norvaline, are widely used in the synthesis of pharmaceutical drugs, such as anti-HIV protease inhibitors or antihypertensive drug. To testify the biosynthetic capacity of chiral amino acids by PsBCAT, a PsBCAT/BsOrnAT coupling reaction system was performed for asymmetric synthesis of the aliphatic amino acids from achiral a-keto acid precursors ( Fig. 5) . In the coupling system, L -ornithine δ-aminotransferase transferred the δ-amino group from L -ornithine to α-ketoglutarate, producing L -glutamate-γ-semialdehyde and L -glutamate. The formation of L -glutamate from generated α-ketoglutarate was strongly favored by the spontaneous cyclization of L -glutamate-γ-semialdehyde to form Δ 1 -pyrroline-5-carboxylate and drove the reaction to the formation of aliphatic amino acids. This enabled the unfavorable thermodynamic equilibrium shift to the synthesis of L -tert-leucine and L -norvaline as well as accelerate the reaction by recycling the inhibitory α-ketoglutarate in the reaction mixture. Since PsBCAT is a thermolabile enzyme (T m = 40°C), the reactions were carried out at 30°C for maintaining the stability of enzymes. In detail, the synthesis of L -tert-leucine and L -norvaline were performed with 0.1 M trimethylpyruvate or 0.1 M α-ketovalerate in 5 mL of 0.5 M Tris-HCl buffer (pH 8.5) containing 20 mM L -glutamate, 80 mM L -ornithine, 20 μM PLP, 0.2 mg PsBCAT, and 0.05 mg BsOrnAT with a yield of 83% L -tert-leucine > 99% e.e. at 42 h and 92% Lnorvaline > 99% e.e. at 22 h respectively (Fig. 5) .
Discussion
Aminotransferases are PLP-dependent enzymes that catalyze reversible transamination reactions between amino acids and α-ketoglutarate. This enzyme is important for the conversion between inorganic nitrogen and organic nitrogen in living organisms. PsBCAT (BCAT from Pseudomonas sp.), comprising 340 amino acids, shows many features typical of bacterial BCATs or BCATs from eukaryotes: a comparable molecular weight, similarities in the secondary, tertiary (fold type IV) and quaternary structure, optimal pH value, activity toward BCAAs, and inhibition by high concentrations of α-keto acids.
Meanwhile, PsBCAT displays broad but typical substrate specificity that catalyzed the overall transamination reaction of various branched chain amino acids and hydrophobic amino acids when α-ketoglutarate was used as an amino acceptor. Distinctively, the enzyme has remarkably high activity with Lallo-isoleucine, L -phenylglycine, L -leucine, L -norvaline, L -valine, L -isoleucine, and L -methionine (229.3, 189.1, 127.0, 117.7, 115.3, 105.1, and 98 .1 U/mg, respectively), whereas other bacterial BCATs only show approximately 10-40 U/mg activities at 37°C. Additionally, PsBCAT shows activities with aromatic L -amino acids, L -histidine, L -lysine, and L -threonine, thus displaying broad amino donor specificity.
Although most ATs catalyze the transfer of the α-amino group of amino acids, some ATs are active toward β-, γ-, and ε-amino groups of amino acids (Calvelage et al. 2017) . Based on the catalyzed reaction and substrate specificity, ATs can be divided into α-ATs and ω-TAs (Buß et al. 2018) . α-ATs catalyze transamination in the presence of a carboxylic acid group in the α-position to keto or amine functionality, whereas ω-TAs transfer the amino group from a carbon atom that does not bear a carboxyl group (Park et al. 2012) . In terms of 3D structure, the active site of ATs is composed of a large pocket and a small pocket (Steffen-Munsberg et al. 2013) . The amino group of the substrate is placed in the middle of the binding pockets toward the PLP cofactor. The molecular mechanism of substrate recognition for BCATs was proposed by Goto based on the analysis of the data on the substrate specificity of EcBCAT and structural data (Goto et al. 2003) . The torsional angle of C3-C4-C4'-N of PLP with Lys185 in the PsBCAT crystal structure is 17°, indicating that the internal aldimine bond (Schiff base, C4′ = N) is essentially coplanar with the PLP ring to make a conjugated π-system of the PLP-Schiff base. The C4′ = N double bond is fixed by the phosphate group, the pyridine hydroxyl group, and the pyridine N atom group (Fig. 4C) . The phosphate group forms hydrogen bonds and salt bridges with Arg83, Ile248, Thr249, and Thr286, and water molecules. The oxygen atom of the PLP pyridine hydroxyl group accepts hydrogen bonds with Tyr190. In fold type I (S)-selective TAs, proton transfer occurs on the si face of the PLP cofactor. However, the re face of the pyridine ring in BCATs faces the functional group of lysine where the proton transfer occurs. Thus, BCATs are the only L -amino acid-specific TAs with the re-specificity of proton transfer.
The major structural difference between BCATs and DATs is the hydrophobicity of the active binding pocket. The histidine and arginine residues are located at the large pocket in DATs, whereas BCAT active sites can accommodate two types of substrates with a hydrophobic side chain (branched chain or aromatic amino acids) and with an acidic side chain (acidic amino acids, Glu) in almost the same positions in the substrate-binding pocket. Sequence alignment and structural superposition of BCATs have shown that the specificity of fold-type IV TAs is determined by two characteristic motifs. The first motif is located at positions 59-63 (corresponding to 36-40 in other BCATs), and the second motif comprises six amino acids at positions 126-128 and 138-140 (corresponding to 95-97 and 107-109 in other BCATs). Phe59, Ile138, and Val140 in the conserved motifs together with Phe14, Phe159, Tyr190, Thr286, and Ala287 are suggested to confer hydrophobic interactions with the hydrophobic or aromatic side chains of the L -amino acids, whereas Tyr54, Tyr126, and Lys128 make a hydrogen-bonding network to stabilize the carboxylate oxygen atom of the amino acids ( Fig. S2A  and S2B ). A comparison of PsBCAT and DrBCAT complex structures shows a distinct dynamic loop (Gly156 to Gly162), which is inferred to block the access of the solvent molecules to the active site, thereby preventing the side process of racemization that occurs in the PLP-dependent alanine racemase with the solvent-accessible active site (Fig. S2C) . The Ala157 residue in PsBCAT, corresponding to Pro157 in other BCATs (Pro174 in DrBCAT), may significantly facilitate the flexibility of the interdomain loop. In addition, Glu197 in BCATs from Escherichia coli (PDB ID: 1IYD) and Thermus thermophilus (unpublished work) (PDB ID: 1WRV) is suggested to confer electrostatic interactions for substrate binding. However, the truncated side chain of the corresponding residue Ala225 in PsBCAT seems to enlarge the large pocket, which might aid in the entry of substrates with bulky moieties.
Previous studies have reported chiral amino acids synthesis using BCAT/OAT BCAT/AspAT, BCAT/AspAT/ PDC, BCAT/ω-AT, and BCAT/GluDH/FDH coupling systems for shifting the equilibrium toward the product direction and circumventing by-product inhibition (Xue et al. 2018) . Each of the coupling systems has individual advantages and shows great application values for the asymmetric synthesis of chiral amino acids, but the major limitation is the catalytic efficiency of BCATs. Therefore, new sources and novel enzymes are still needed to be mined to adapt to these systems. To testify the compatible of our newly discovered PsBCAT with such coupling systems for chiral amino acids synthesis, the BCAT/OAT coupling system was used in the asymmetric synthesis of L -tert-leucine and L -norvaline. The PsBCAT/BsOrnAT coupling reaction produced 83 mM L -tert-leucine with > 99% e.e. from 100 mM trimethylpyruvate for 42 h and produced 92 mM L -norvaline with > 99% e.e. from 100 mM α-ketovalerate, which proves the compatibility of PsBCAT with above systems and the potential of industrial applications. It is worth mentioning that addition of fresh enzymes in the reaction mixture at late stage did not improve the conversion of L -tert-leucine. This suggested that the coupling system has reached thermodynamic equilibrium, which is in agreement with the results of previous report (Li et al. 2002) . Future work will examine the optimal conditions for asymmetric synthesis bioprocess, including the screening amino donor recycling systems, and the separation and purification of products.
In conclusion, we determined the crystal structure of branched-chain amino acid aminotransferase from Pseudomonas sp. The enzyme is active toward typical BCAT substrates, including L -leucine, L -isoleucine, and L -valine, and also shows significant activity with aromatic L -amino acids, Lhistidine, L -lysine, and L -threonine. The structure of PsBCAT is similar to the known structures of bacterial BCATs. However, we found some differences in the organization of the substrate binding cavity, which may influence the substrate specificity and activity of the enzyme. Taking into account a broad range of accepted substrates and detected ability to catalyze asymmetric synthesis of L -tert-leucine and L -norvaline, this enzyme holds promises in biotechnological applications, and the structural fingerprint will aid in further engineering to increase the activity with other chiral amino acids.
